01 5NOVARTIS
01 110398791
02 110406240
03 111318121
04 111951190
05 112208102
01 3Y
02 2Blank
01 3Y
02 2Blank
01 22028-08-15
02 12034-10-17
03 12035-11-12
04 12041-09-18
Patent Expiration Date : 2028-08-15
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
US Patent Number : 11318121
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 215833
Patent Use Code : U-3345
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-08-15
Patent Expiration Date : 2041-09-18
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
US Patent Number : 12208102
Drug Substance Claim :
Drug Product Claim :
Application Number : 215833
Patent Use Code : U-3345
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-18
Patent Expiration Date : 2028-08-15
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
US Patent Number : 10406240
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 215833
Patent Use Code : U-3345
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-08-15
Patent Expiration Date : 2035-11-12
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
US Patent Number : 11951190
Drug Substance Claim :
Drug Product Claim :
Application Number : 215833
Patent Use Code : U-3345
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-11-12
Patent Expiration Date : 2034-10-17
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
US Patent Number : 10398791
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 215833
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-10-17
